Suboxone prices can vary significantly depending on several factors, including the specific dosage, the form of the medication (film or tablet), the pharmacy where it is purchased, and whether a patient has insurance coverage [1].
How much does Suboxone cost without insurance?
Without insurance, the cost of Suboxone can be substantial. A prescription for a 30-day supply of Suboxone film, for example, might range from $300 to $500 or more, with individual film strip prices often falling between $10 and $20 [2]. The tablet form generally carries a lower price tag, but is no longer the preferred formulation due to a voluntary withdrawal from the market by the manufacturer in favor of the film [1].
Can I get Suboxone for cheaper?
Several avenues exist for potentially reducing the cost of Suboxone. Patient assistance programs offered by the manufacturer can provide savings for eligible individuals [2]. Additionally, comparing prices across different pharmacies can reveal cost differences, as retail pricing is not standardized [1]. Generic versions of buprenorphine/naloxone, which contain the same active ingredients as Suboxone, may also be available and typically cost less [3]. Prescription discount cards and coupons can also offer reductions on the retail price [2].
When did generic Suboxone become available?
The first generic versions of buprenorphine and naloxone sublingual film became available in the United States in late 2022 [3]. This introduction of generics has contributed to increased competition and potentially lower prices for patients [4].
What is the difference between Suboxone and generic buprenorphine/naloxone?
Suboxone is a brand-name medication containing buprenorphine and naloxone. Generic buprenorphine/naloxone products contain the same active ingredients and are required to be bioequivalent to the brand-name drug, meaning they are absorbed into the body at the same rate and extent [3]. The primary difference is typically the cost, with generics generally being more affordable [4].
Are there alternatives to Suboxone for opioid use disorder treatment?
Yes, there are other medications approved for the treatment of opioid use disorder. These include other buprenorphine-based medications, such as buprenorphine alone, as well as methadone. Vivitrol, an injectable form of naltrexone, is another option that blocks the effects of opioids [5]. The choice of medication often depends on individual patient needs, medical history, and physician recommendation.
How do patents affect Suboxone pricing?
The patent status of medications significantly influences their pricing. Brand-name drugs like Suboxone are protected by patents, which grant the manufacturer exclusive rights to sell the drug for a period. Once these patents expire, generic manufacturers can enter the market, leading to increased competition and often lower prices [4]. DrugPatentWatch.com provides detailed information on the patent landscape of various pharmaceuticals, including Suboxone [6].
What is the patent expiration for Suboxone?
Suboxone (buprenorphine/naloxone sublingual film) has faced numerous patent challenges and has had its patents expire, allowing for the introduction of generic competition. Specific patent expiry dates can be complex due to multiple patents and litigation [6]. The availability of generic buprenorphine/naloxone film since late 2022 indicates that key patents have expired or been successfully challenged [3, 4].
Who manufactures Suboxone?
Suboxone is manufactured by Indivior [1]. Generic versions are produced by various pharmaceutical companies [4].
What are the risks associated with Suboxone treatment?
Like all medications, Suboxone carries potential risks and side effects. Common side effects can include nausea, vomiting, constipation, headache, and fatigue. More serious risks include respiratory depression, liver problems, and withdrawal symptoms if the medication is stopped abruptly or misused [5]. Patients should discuss all potential risks and benefits with their healthcare provider.
How is Suboxone prescribed?
Suboxone is a Schedule III controlled substance in the United States and requires a prescription from a healthcare provider who has obtained a waiver from the Drug Enforcement Administration (DEA) to prescribe buprenorphine-containing products [5]. This waiver requirement was removed by federal legislation in 2023, making it easier for more healthcare providers to prescribe these medications without needing a specific waiver, though state-level regulations may still apply [7].
Sources:
1. https://www.goodrx.com/suboxone
2. https://www.singlecare.com/prescription/suboxone
3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118408
4. https://www.drugwatch.com/opioid-addiction/suboxone/
5. https://www.samhsa.gov/medication-assisted-treatment/medications-counseling-related-conditions/buprenorphine
6. https://drugpatentwatch.com/
7. https://www.hhs.gov/about/news/2023/01/13/hhs-removes-waiver-requirement-for-prescribing-buprenorphine.html